Here, the authors provide mechanistic insights into how decitabine-induced DNA hypomethylation can potentially overcome endocrine resistance in ER+ breast cancer, by targeting the 3D epigenome to resolve gene deregulation and suppress tumor growth.
- Joanna Achinger-Kawecka
- Clare Stirzaker
- Susan J. Clark
